Publisher
Springer International Publishing
Reference12 articles.
1. Bruckert, E., Simonetta, C., & Giral, P. (1999). Compliancy with fluvastatin treatment characterization of the noncompliant population within a study population of 3845 patients with hyperlipidemia. CREOLE Study Team. Journal of Clinical Epidemiology, 52, 589–594.
2. Burrell, C. D., & Levy, R. A. (1984). Therapeutic consequences of noncompliance. In Improving medication compliance. Proceedings of a symposium (pp. 7–16). Washington, DC: National Pharmaceutical Council.
3. DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101–2107.
4. DiMatteo, M. R., Haskard-Zolnierek, K. B., & Martin, L. R. (2012). Improving patient adherence: A three-factor model to guide practice. Health Psychology Review, 6(1), 74–91.
5. Hayes, T. L., et al. (2009). Medication adherence in healthy elders: Small cognitive changes make a big difference. Journal of Aging and Health, 21(4), 567–580.